Heron Therapeutics, Inc. (HRTX) — Analysis Summary
Heron Therapeutics, Inc. (HRTX) has a market cap of $164.69M with year-over-year revenue growth of +7.4%. Net margin stands at -13.0%. The stock trades at a P/E ratio of -5.3.
Key Takeaways
- Revenue changed +7.4% year-over-year
- Net margin of -13.0%
- P/E ratio of -5.3
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, HRTX posted revenue growth of +7.4% and trades at a P/E of -5.3.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.